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Stability of Intrinsically Disordered Regions of two Transcription Factors by Molecular Dynamics
Abstract
Intrinsically Disordered Proteins have regions that lack a stable structure under
physiological conditions, yet they constitute an ensemble of conformations. Intrinsi-
cally Disordered Proteins are present in many biological functions, like the regulation
of transcription. The altered regulation of Intrinsically Disordered Proteins is associ-
ated with many human diseases. The possibility of inhibiting Intrinsically Disordered
Proteins is of great importance to chemical biology and drug discovery. Transcription
Factors, like Glucocorticoid Receptor and c-Myc, are examples of proteins that con-
tain large disordered regions. c-Myc disordered regions are associated with Burkitt’s
lymphoma and therefore it is considered a promising drug target.
In this work we studied, by Molecular Dynamics simulations, a peptide fragment
(from residue 187 to 202) of a disordered region of Glucocorticoid Receptor. Using
the same methodology, we chose a peptide fragment (from residue 42 to 63) of a
disordered region of c-Myc, to study it alone and with a ligand, which represents a
model drug compound against Lymphoma. The major findings from this work are:
• The data on the fragment of the Glucocorticoid Receptor showed an inverse
correlation between relative activity and disorder;
• Single mutation of peptide fragments of the Glucocorticoid Receptor did not
show a general trend between experimental biological relative activity and the
its stability;
• The substitution of Prolines have both a destabilising and stabilising effect in
peptide fragment of c-Myc;
• Hydrophobic contacts points are the most important kind of interaction be-
tween a peptide fragment of c-Myc and the ligand;
• Our data also suggest the ligand is bound to the residues located at the middle
of the peptide fragment of c-Myc more specifically to the Isoleucine (I49),
Tryptophan (W50) and Phenylalanine (F53);
• As future perspectives this work might constitute the basis of further evalua-
tion of the ligand as a drug with the possibility to inhibit c-Myc activity, with
great importance to for drug discovery.
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Stability of Intrinsically Disordered Regions of two Transcription Factors by Molecular Dynamics
Resumo
As Proteínas Intrinsecamente Desordenadas possuem regiões que, em condições
fisiológicas, não têm uma estrutura estável, apesar disso formam conjuntos de con-
formações. As Proteínas Intrinsecamente Desordenadas participam em várias ativi-
dades biológicas, entre as quais a regulação da transcrição. A desregulação de
Proteínas Intrinsecamente Desordenadas tem sido associada com várias doenças,
pelo que, a possibilidade de as inibir, pode conduzir a novos fármacos e terapias.
Fatores de Transcrição, como o Recetor da Glucocorticoide ou c-Myc, são exemplos
de proteínas que possuem regiões desordenadas. A proteína c-Myc está associ-
ada ao linfoma de Burkitt e, como tal, é considerado um potencial alvo para novas
terapias.
Neste trabalho foi estudado, recorrendo a simulações de Dinâmica Molecular,
um fragmento peptídico (dos resíduos 187 a 202) de uma região desordenada do
Recetor do Glucocorticoide. Utilizando a mesma metodologia, foi escolhido um frag-
mento peptídico (do resíduo 42 a 63) de uma região desordenada da proteína c-Myc,
a fim de a estudar sozinha e com um ligando, que poderá servir como modelo de
uma nova terapêutica. Dos resultados deste trabalho, destaca-se os seguintes:
• Verificou-se que a desordem do fragmento do Recetor do Glucocorticoide é
inversamente proporcional à atividade biológica;
• Mutações dos fragmentos do Recetor do Glucocorticoide não mostram re-
lação evidente entre a atividade biológica e a estabilidade;
• As substituições de Prolinas nos fragmento de proteína c-Myc demonstraram
ter efeitos tanto estabilizador como destabilizador;
• Os contactos hidrofóbicos são o tipo de interação mais importante entre o
fragmento da proteína c-Myc e o ligando;
• Os dados também sugerem que o ligando se liga aos resíduos localizados
na porção média do fragmento da proteína c-Myc, mais especificamente à
Isoleucina (I49), Triptofano (W50) e Fenilalanina (F53);
• Estes resultados perspectivam um trabalho futuro de avaliação do ligando
como fármaco inibidor da actividade c-Myc, de grande importância para a
descoberta de novos fármacos.
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1 Introduction
1.1 Intrinsically Disordered Proteins
In 1894, Emil Fischer recognised the lock-and-key mechanism, in which enzymes
and the substrate are compared to a lock being opened by a key [1]. In this analogy,
enzymes need a well-defined structure so as to bind to the substrate and conse-
quently fulfil their function. This correlation between structure and function led to
the creation of protein structure-function paradigm [1, 2].
Years later, in 1978, proteins that do not follow the paradigm were discovered
[1]. Nowadays it is possible to isolate function by genetic methods as using mu-
tants and knockouts and these methods allow identification of unfolded proteins [3].
These proteins have regions that lack stable secondary or tertiary structure but are
functional [1, 2, 4–8]. Many terms were used to describe such regions like natively,
naturally, inherently or intrinsically and unfolded, unstructured, disordered or dena-
tured [1]. Currently these proteins are known as Intrinsically Disordered proteins [1,
2, 4] and their research has grown extensively [3].
1.1.1 Amino Acids
Before the discovery of Intrinsically Disordered proteins, in 1973, Christian Anfinsen
proved the amino acid sequence of a protein encodes the information for its folding
[5]. In the case of globular proteins, which are rich in hydrophobic amino acids,
fold into a hydrophobic core [7]. On the opposite case, for Intrinsically Disordered
proteins, their sequence explains their inability to fold [5, 6, 8, 9] and, in its regions,
amino acids are often charged or polar, whereas hydrophobic are scarcer [6, 7, 9–
13]. See table 1.1. Therefore they lack a hydrophobic core and the charge distribu-
tion destabilises the structure affecting its extension [6, 11, 12]. Furthermore, it was
suggested the amino acid composition of Intrinsically Disordered regions might be
more important than the specific sequence itself [2]. Amino acids inside a protein
or a peptide fragment are mentioned as residues and this terminology will be used
here.
1
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Table 1.1: This table links amino acids and disorder. The first part
describes the amino acid composition of Intrinsically Disordered
regions. The second part ranks the amino acids according to their
disorder properties.
Intrinsically Disordered Regions [6]
Rich in Arg, Gln, Glu, Lys, Pro, and Ser
Deficient in Cys, Ile, Leu, Phe, Trp, Tyr, and Val
Similar levels with folded proteins Met and Thr
Enriched in some and depleted in others Ala, Asn, Asp, Gly and His
From order to disorder promoting [7]
Trp, Phe, Tyr, Ile, Met, Leu, Val, Asn, Cys, Thr, Ala, Gly, Arg, Asp, His, Gln, Lys,
Ser, Glu and, at last, Pro
1.1.2 Structure
Intrinsically Disordered regions can be just a few residues long, extensive loops or,
usually, protein ends [6, 7]. Since Intrinsically Disordered regions lack an hydropho-
bic core, they do not fold spontaneously into the compact states as the ones found
in the Protein Data Bank [13]. That is, Intrinsically Disordered Proteins have re-
gions that lack stable secondary or tertiary structure under physiological conditions
[1–12, 14]. Instead, Intrinsically Disordered proteins are dynamical ensembles of
flexible interconverting conformational sub-states with low energy barriers [1, 3, 5,
8, 10, 12]. These sub-states cannot be described by the position of their atoms and
backbone angles, as they do not define a unique structure[1, 5, 8].
Even so, Intrinsically Disordered proteins are never completely random coils,
they are also likely to generate regions of secondary structure [13]. The amount of
this secondary structure varies and, depending on it, Intrinsically Disordered proteins
turn out more compact or extended [5]. If it is extended, is described as being in
random coil [5, 7, 13], which means the coil has random backbone angles [13]. See
figure 1.1a. In case an Intrinsically Disordered protein exhibits a more compact con-
formation, it is molten globule [5, 7, 13]. See figure 1.1b. If Intrinsically Disordered
proteins actually have globular domains divided by Intrinsically Disordered linkers,
they are modular, as beads on a string [13]. See figure 1.1c. Yet these flexible link-
ers, when bound, achieve a structure [13]. Hence Intrinsically Disordered regions
structure not only depends on its amino acid sequence, but also on its environment
[8].
2
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(a) Random coil (b) Molten globule
(c) Linked folded domains
(like beads on a string)
Figure 1.1: Representation of different conformations of Intrinsi-
cally Disordered proteins. Adapted from [13].
1.1.3 Interactions
In general, upon interacting with a ligand, Intrinsically Disordered proteins normally
fold into a well-defined structure, meaning they go through coupled binding and fold-
ing [2–6, 13]. While the unbound protein does not have a stable structure, the
complex has [6]. See figure 1.2. The folding process corresponds to a balance be-
tween the decrease of the entropy with disorder-to-order transition and the decrease
of enthalpy [3, 5, 6, 13, 14]. The entropic cost enables Intrinsically Disordered
proteins to interact with high specificity and low affinity [2, 4, 11, 13], so their inter-
actions are precise but weak and brief [10, 11]. In other words, this allows them to
associate and dissociate quickly and easily [2].
Besides, due to the structure extension, Intrinsically Disordered proteins have
a wider interaction surface area compared to globular proteins of the same length
[4]. Intrinsically Disordered proteins bind to several partners namely proteins, such
as themselves, nucleic acids and others [2, 8]. Additionally, their interactions may
include the binding of many different regions to one partner, see figure 1.3a, and
one region to many different partners, see figure 1.3b [8]. This second one is possi-
ble because Intrinsically Disordered proteins have binding sites in quick succession
and fold differently depending on the ligand [2, 3, 8]. Given these multiple binding
possibilities, it is possible to infer that ligands may compete for the binding [8].
Along with coupled binding and folding, Intrinsically Disordered proteins also ex-
perience allosteric effects. Allostery is a change of structure induced by the binding
to a first ligand, which alters the binding affinity to a second ligand [15]. The interfer-
ence of allosteric effects cannot be disregarded in Intrinsically Disordered proteins.
For example, a certain domain may have an allosteric response to the binding to a lig-
and of another domain. As a consequence, this domain can have its binding affinity
increased/decreased. Being so, a specific ligand behaves as an agonist/antagonist
depending on the previous state in the ensemble [9].
3
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Figure 1.2: The portrayal of the free energy landscape: on the
top, the free energy of an unbound Intrinsically Disordered protein;
on the bottom, the free energy of Intrinsically Disordered protein
binding. The unbound protein is illustrated by a flat surface, in
contrast with the bound protein, which shows a distinct minimum.
Adapted from [14].
(a) The sketch shows two Intrinsically Disordered protein with different
binding regions, small dark and light green boxes, and a ligand, light green
circles. The picture illustrates the binding of many Intrinsically Disordered
regions to one ligand.
(b) The sketch shows an Intrinsically Disordered protein with its binding
regions, small dark green boxes, and two different ligands, dark and light
green circles. The picture illustrates the binding of one Intrinsically Disor-
dered region to many ligands.
Figure 1.3: Representations of Intrinsically Disordered proteins
binding to their ligands. Adapted from [4].
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1.1.4 Function
Intrinsically Disordered proteins have a range of functions, which complement the
functions of ordered proteins [7]. Regarding Intrinsically Disordered proteins, the
broader significance of their ”structures” benefits their function [1, 3]. Such advan-
tages include binding to numerous partners and being involved in different interac-
tion pathways as hubs [3, 4]. Also, their interactions have fundamental features for
signalling functions. Signalling processes are initiated with high associating speci-
ficity; when a process is finished, the low affinity allows a quick dissociation [4, 13].
Beyond signalling, Intrinsically Disordered proteins are known for cell cycle control,
regulation of transcription and translation, recognition of DNA, RNA and other pro-
teins, supporting in the folding proteins and RNA, determining cell’s response to an
external stimulus [1, 2, 6–8, 10, 11]. Conversely, Intrinsically Disordered proteins
are usually not involved in control of metabolism, biosynthesis, transport and other
functions that entail a specific structure [1, 11].
1.1.5 Regulation
Tight regulation of Intrinsically Disordered proteins enables fidelity in their functions.
This control is provided at various levels [4, 5] and it aims to preserve equilibrium,
as the proper concentration, post-translational modifications, position and lifespan
in the cell [4].
Regulation of the availability
As an Intrinsically Disordered region can bind to many different partners and differ-
ent regions can bind to the same partner (described before in 1.1.3), it is suggested
they are capable of binding to each other’s partners and also that these interactions
are more likely to occur in a higher concentration of Intrinsically Disordered proteins
[4]. See figure 1.4. Such a promiscuous behaviour may cause non-functional in-
teractions, destabilising signalling pathways, thus leading to undesirable outcomes.
Therefore, Intrinsically Disordered proteins regulation controls their availability, by
being present in proper levels and no longer than required, which generally results
in lower amounts and for shorter intervals than ordered proteins [4]. See figure 1.5.
In spite of that, not every Intrinsically Disordered protein in a situation of increased
expression is harmful. In certain circumstances as being under stress, in a pre-
cise period of the cell cycle or in reaction to certain stimuli, could require a higher
availability [4].
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Figure 1.4: The sketch shows an Intrinsically Disordered protein
with its binding region, small dark green box, and two different lig-
ands, dark and light green circles. The top illustrates the proper
availability, a functional interaction is achieved. The bottom illus-
trates an increased availability, not only functional interaction but
also non-functional interactions are achieved. Adapted from [4].
Figure 1.5: Hypothetical ”Availability-outcome” landscape of an
Intrinsically Disordered protein. Proper availability generates a de-
sired outcome (blue region); altered availability generates an unde-
sired outcome (red region). Adapted from [4].
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1.1.6 Diseases
Intrinsically Disordered proteins have been involved in pathological mechanisms of
human diseases, in more than one way. In one hand, the concept of controlled-chaos
arose from the regulation of Intrinsically Disordered proteins, being the uncontrolled-
chaos recurrently connected with diseases [5]. On the other hand, the amino acid
composition and its tendency to develop beta-structures, such as -sheets and -
turns, has been described as another mechanism. These cause higher aggrega-
tion potentials with propensity to create structures of the amyloid kind [10]. Thus
Intrinsically Disordered proteins are found related with diseases mainly by loss of
regulation or aggregation effect: different cancers, Alzheimer’s, Parkinson’s, cardio-
vascular diseases, diabetes, neural diseases, prion diseases, accelerated fibrillation,
protein deposition diseases, among others [1, 5, 10, 11]. Because of the connec-
tion to these illnesses, Intrinsically Disordered proteins are becoming potential drug
targets, where the target is the Intrinsically Disordered protein itself or the protein-
protein interactions [10].
1.1.7 Drug targets
Recent medicines treatments only have made use of less than 10% of reasonable
potential targets, which are exclusively around 500. Besides, roughly 70% of these
drug targets are restricted to membrane receptors and enzymes [16].
Moreover, it was mentioned healthcare and pharmaceutical industry suffered
serious drop of income [17]. This was due to further demanding requirements for
regulating procedures, growing cost-constrained healthcare systems and patent ex-
pirations. To overcome this situation, they seek new additional ground breaking,
reasonable priced and effective drugs [17].
For the new drug molecules, targeting protein-protein interactions is a likely ap-
proach. As mentioned, Intrinsically Disordered proteins bind to proteins, so they
establish such described interaction. This kind of interaction produces a response
upon external stimuli. Blocking it with a small molecule is an attractive therapeu-
tic intervention. The possibility to inhibit Intrinsically Disordered proteins is of great
importance to chemical biology and drug discovery [16].
1.2 Transcription Factors
Transcription Factors are an example of proteins that contain large disordered re-
gions [18]. Their function is to control gene expression by recognising and binding
to specific DNA sequences [19, 20]. Transcription Factors identify around 6 to 12
7
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base pairs and bind to regulatory regions [20, 21]. These proteins regulate through
activating or repressing transcription [19] and, when inducing transcription, Tran-
scription Factors operate together with RNA polymerase, co-factors and others [22].
Transcription Factors are influenced by several factors such as the nucleus activity,
accessible DNA binding sites and the activation previous state [9, 19].
1.2.1 Glucocorticoid Receptor
Glucocorticoid receptor is a member of a family of nuclear receptors [23–25]. Glu-
cocorticoid Receptor is a modular protein, so each domain is capable of preforming
distinct functions [23, 26]. In general, nuclear receptors can be divided in ligand
binding domain (LBD), DNA binding domain (DBD), hinge region and N-terminal
(NTD) [9, 27]. See figure 1.6 and table 1.2.
As the name implies, Glucocorticoid Receptor is a receptor of glucocorticoids
[24, 26], which are steroid hormones (cortisol, for example), and they are produced
in the adrenal cortex [28]. Glucocorticoids are involved in immunosuppressive and
anti-inflammatory functions, gluconeogenesis, lipolysis and decomposition of pro-
teins [28]. Inactive Glucocorticoid Receptor are located in the cytoplasm, in a com-
plex with heat shock proteins [24, 26]. Once glucocorticoids bind to these Gluco-
corticoid Receptors, they dissociate from the complex with heat shock proteins and
turn active. Following this, the receptor and its ligand move into the nucleus and
bind as a homodimer to specific DNA sequences [23–25]. These DNA sequences,
called glucocorticoid response elements, are located in the surrounding of the target
genes and regulate their activity [24, 25, 27].
An activation or transactivation domain is a small region of the protein with the
capacity to activate transcription [29]. In nuclear receptors there are at least two
activation domains. One, the activation function 1 (AF1), is located in the NTD and
it is ligand-independent. The other, activation function 2 (AF2), is positioned in the
LBD and it is ligand-dependent [9, 29]. In humans, AF1 is more active and situated
between residues 77 and 262. In opposition, AF2 is a minor domain and located
between residues 526 and 556 [23–25]. There is a third conserved region in the
C terminus that may participate in the transactivation activity [23, 24]. Regarding
AF1, also known as 1, it encloses a region with near 60% or 70% of the activity of
the entire domain. This region is called the 1 core and is a sequence of 58 amino
acid from 185 residues of 1 [23–25]. See figure 1.6. Even though its function, 1
and 1 core were proven to be unstructured in aqueous solution [24].
8
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Table 1.2
Ligand Domain where the typical small ligands bind; domain
Binding conformation and protein activity varies with the
Domain ligand bound;[9]
DNA Domain sensitive to DNA sequences of its response
Binding elements; response elements are a specific DNA
Domain sequence where the protein binds;[9]
N-terminal Domain with high Intrinsically Disordered content;
Domain domain with allosteric effects on LBD and DBD;[9]
Hinge region Domain that links DBD and LBD;[27]
Figure 1.6: Schematic representation of the human Glucocorticoid
Receptor and of its the 1 core transactivation domain. Model
is constituted by globular ligand binding domain (green), globular
DNA binding domain (blue), hinge region (pink) and disordered N-
terminal domain (yellow). The locations of the-helixes are shown.
The sequence of 1 core (HRI) is displayed. Adapted from [9, 23].
9
Chapter 1. Introduction
1.2.2 c-Myc
c-Myc, in short Myc, is a transcriptional factor that regulates several biological func-
tions. These include cell growth, cycle and survival, metabolism and energy pro-
duction, proliferation, differentiation and apoptosis [30–34]. c-Myc is an example
of a hub by assimilating various pathway signals and controlling many functions
[32]. See figure 1.7. c-Myc levels are highly regulated at MYC gene expression,
protein stability and others [32]. Nonetheless these turn out deregulated in many
cancers [30, 32, 33]. For example, in Burkitt’s lymphoma, MYC gene is frequently
found mutated [32]. c-Myc abnormal expression may lead to a cell transformation,
proliferation and resistance to apoptosis in hypoxia, external stress and other hos-
tile factors of microenvironments [33]. With such noticeable association to cancer,
c-Myc was considered a promising drug target [32].
Figure 1.7: Representation of the biological functions associated
with c-Myc in the cell, acting as a central hub. Adapted from [32].
10
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C-Terminal
c-Myc has a basic helix-loop-helix (bHLH) DNA binding and a leucine zipper (LZ)
dimerisation motifs. c-Myc heterodimerises with its partner protein Max in order to
bind DNA with CACGTG sequence [30–32]. See figure 1.8. Max is essential for
c-Myc’s transcriptional activities, therefore essential for c-Myc’s function [32].
Figure 1.8: Heterodimer of c-Myc (red) and Max (blue) proteins
binding to DNA. Adapted from [35].
N-Terminus
In the N-terminus of c-Myc, there are regions with high sequence conservation be-
tween species and these regions are called Myc Boxes (MB) [32]. The first, MBI is
positioned between the residues 47 and 63 [31]. MBI is able to regulate c-Myc by its
two phosphorylation sites: T58 and S62 [31, 32]. See figure 1.9. The phosphoryla-
tion of S62 activates c-Myc and the sequential phosphorylations of S62 and T58 are
initial steps of c-Myc degradation pathway [32, 34]. Mutations around T58 and S62
are connected to cancers as Burkitt’s lymphoma [30–32, 34]. These interfere with
T58 phosphorylation, which gather and hold c-Myc activated in S62-phosphorylated
state [31, 34]. Hence, MBI is fundamental to set c-Myc activity time frame (c-Myc
half-life is 20-30min) [31].
Even though N-terminal is considered disordered, there are two regions of tran-
sient secondary structure. One is located from the amino acid 22 to 33 and the
other region overlaps MBI. This last region, has two segments: between residues 48
and 55, with helical properties, and between residues 56 and 65, with fluctuating
extended character possibly stabilised by a proline enriched sequence.[31]
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Figure 1.9: Schematic representation of c-Myc protein, location of
MBI domain and its phosphorylation sites. It is also identified the
region with helical properties (red box) and between the region with
fluctuating extended character (red arrow). Adapted from [31].
1.3 Molecular Dynamics Simulations
“Certainly no subject or field is making more progress on so many fronts at the
present moment than biology, and if we were to name the most powerful assump-
tion of all, which leads one on and on in an attempt to understand life, it is that all
things are made of atoms, and that everything that living things do can be under-
stood in terms of the jigglings and wigglings of atoms.”[36]
Molecular dynamics is a valuable tool that provides information of a system by
simulating the motion of particles over time [37]. In here, particles usually mean
atoms. Specifically, it informs about conformations, system in equilibrium and ther-
modynamic parameters [38]. When applied to a biological system, like proteins,
improves the understanding of the biological phenomena [37].
Compared to experiments, this computational approach has advantages, for
instance being easier to measure certain properties. Nonetheless experimental ap-
proaches allow assessing the accuracy of the simulations results and improving
methodology [38]. Actually, the computational and experimental approaches should
be regarded as complementary techniques. See figure 1.10.
Programs like CHARMM, Amber and GROMACS are examples of molecular dy-
namics simulations programs [39, 40].
12
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Figure 1.10: Interactions between experimental and computational
approaches. Adapted from [41]
1.3.1 Force Field
In order to calculate the particles motion, a potential energy function must be defined
[37, 39]. It is through this potential that forces can be calculated and subsequently
obtained the equations of motion. For simple systems of few and small molecules,
the potential energy function could be achieved by quantummechanics calculations.
However, most systems, like proteins or other macromolecules, are not so simple.
They require an empiric potential function, which is based on classical mechanics of
fixed point charges [37, 42]. The potential energy function is also called force field.
Some examples of force fields are CHARMM22 force field for proteins, CHARMM27
force field for nucleic acids, AMBER nucleic acid, OPLS force field [42].
Typically the potential energy function U has two contributions: interaction of
bonded and non-bonded atoms [37, 40, 42]. See (1.1). The bonded interaction
contribution (Vl+V+V) to the force field is characterised by the length, angles and
dihedral angles of bonds between atoms. The non-bonded contribution is constituted
by the electrostatic potential VCoulomb and the Lennart-Jones potential VLJ .
U = Vl + V + V' + VCoulomb + VLJ (1.1)
Bonded contibutions
The componentsVl and V are represented by harmonic potentials, where the length
l and angles , respectively, correspond to a displacement x [37, 39, 40, 42].
They correspond to the stretching and twisting of bonds. In the harmonic potential
13
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function as Vx, x0 represents the equilibrium value. See (1.2). The component
V' is a periodic potential, so the potential is expressed as sinusoidal function of
dihedral angles ' [37, 39, 40, 42]. See (1.3). In here,  is the phase shift and n is
the periodicity of '.
Vx =
X
x
Kx(x  x0)2 (1.2)
V' =
X
'
K' [1 + cos (n'  )] (1.3)
Non bonded contibutions
The non-bonded component is the sum of electrostatic potential vij and the Lennart-
Jones potential uij of each non-bonded pairs of atoms i and j [37, 40, 42]. See
(1.4).
VCoulomb + VLJ =
X
ij
(vij + uij) (1.4)
The electrostatic potential vij represents the interaction between the charges qi
and qj . This contribution can be attractive or repulsive, according to the charges qi
and qj signs. See (1.5) [37, 40, 42].
vij =
qiqj
4"rrij
(1.5)
The Lennard-Jones potential uij is a function with both repulsive and attractive
terms and also forms a minimum. See (1.6). The repulsive term is due to of core-
core repulsion and the attractive is due to van der Waals interaction. Here,  defines
u(r = ) = 0 and  is u(r = rmin) = , where rmin is the distance at the
minimum potential.[37, 40, 42, 43] See figure 1.11.
uij = 4
24 
rij
!12
 
 

rij
!635 (1.6)
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Figure 1.11: Graph showing Lennard-Jones potential. Adapted
from [43].
Parameters
The force field, besides being a function, also consists of parameters. For instance,
Kx, x0 K', n, , "r, ,  are parameters. The parameters Kx and K' are force
constants. "r is the relative dielectric constant. These are obtained by quantum
mechanics calculations or experimental methods [37, 40, 42].
1.3.2 Particles motion
Having a potential energy function, it is possible to determine the forces established
between the atoms and subsequently achieve the particles motion [39, 40]. By the
definitions of work W in (1.7) and potential energy U in (1.8), the force ~F is the
negative of the gradient of potential energy function. See (1.9).
W =
Z
c
~F  d~r (1.7)
W =  U (1.8)
 ~rU = ~F (1.9)
According to the second Newton’s law, the velocity ~v of a particle can be cal-
culated by the temporal integration of its force ~F and the position ~r by a double
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temporal integration. The constant m is the mass of the particle. See (1.10).
~F = m
d2~r
dt2
(1.10)
In molecular dynamics simulations, it is used algorithms called dynamics inte-
grators in order to integrate force [42]. An example of a dynamics integrator is Verlet
algorithm, which is based on Taylor series expansions [39]. See (1.11). Here r(t)
is the position in a single dimension at the instant t and t is the time interval of
the between the previous and following position.
r(t+t) = 2r(t)  r(t t) + F
m
t2 +O(t4) (1.11)
1.3.3 Running the simulations
The figure 1.12 is a diagram of the molecular dynamic process to run a simulation.
Molecular Dynamics simulations require a initial set of the structure. This can be
given by experimental methods or by building a model [40]. Generally, the structure
could be imported form a PDB file. Then the force field and its characteristic must
be chosen [42].
Afterwards, it is necessary to optimise the system structure. The optimisation
uses an iterative minimisation algorithm. One of the simplest method is steepest
descent. Generally, more than one algorithm can be employed, for instance the
Adopted-Basis set Newton-Raphson method is performed following the steepest de-
scent method.[42]
With the structure refined, the system is ready for a heating process. At first,
atoms are assigned random velocities from a maxwellian distribution associated with
a low temperature. Then, each time the temperature is increased, a new set of
random velocities from the distribution are assigned. The relation between the mean
velocity hvii of the atom i and temperature T is given by equation (1.12) [37]. Here,
N is the total number of the atoms, mi is the mass of the atom i and kB is the
Boltzmann constant.
1
2
NX
i=1
mihvi2i = 3
2
NkBT (1.12)
When the temperature stabilises, atoms have random velocities from the cor-
responding maxwellian distribution and the whole system has the same average
temperature. Then all is set to run the simulations as a function of time: con-
tinue integrating the equations of motion, generating coordinates and velocities time-
dependent [37].
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Set the system

Import the system and select the force field and characteristics
Optimise the structure

Employ an iterative minimisation algorithm
Heating process

Atoms are assigned certain velocities as temperature rises
Molecular dynamics Run simulations as function of time
Figure 1.12: Diagram of the molecular dynamic process. On the
left, there are four essential steps in order. On the right, there are
descriptions of each step. From [37]
1.3.4 Accuracy vs speed
Molecular Dynamics simulations poise between accuracy and speed.[42] For ex-
ample, a more accurate force field can lower the speed. So the force field must be
adapted to the system for a better performance, which means more or less contribu-
tions are taken into account. An example of additional contribution is the backbone
dihedral angle correction term. It corrects minor systematic errors in the protein
backbone description. This term is based on quantum mechanical calculations and
structure-based potentials of mean force [42].
Additionally, the non-bonded contributions can be only calculated for distances
within a cutoff limit. This is to reduce numbers of non-bonded pairwise interactions
taken into account and speeds the calculations [42]. When cutoff is used, it is
advised to also use the force-shift methods. They smooth the forces near the cutoff
distance, in order to go to zero in a continuous manner [42].
Since the environment has a great impact on the protein behaviour, proteins
are frequently solvated, thus being important to simulated a solvent.[37, 42] Once
again, there are options of how to represent the solvent: explicit or implicit. In
explicit solvent, water molecules are simulated and the system is composed of many
more atoms; in implicit solvent, the relative dielectric constant "r becomes distance-
dependent [38, 42].
Other concept to consider in molecular dynamics is the system boundary con-
ditions. One type of boundary conditions is the periodic boundary conditions. The
point is to simulate an infinite system by repeating the central cell as if there were
17
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no actual boundaries, in order to minimise the effect of the boundary on the system
[42].
There is the possibility to apply SHAKEmethods to impose holonomic constraints
too. These constraints are able to fix the hydrogen bonds length, when they can be
disregarded. SHAKE usage allows a longer timestep in the integration, like 2 fs [42].
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2 Objectives
In this work, it is proposed to:
1. Improve the understanding of stability of Intrinsically Disordered regions of
proteins like Glucocorticoid Receptor and c-Myc;
2. Evaluate a novel compound, which could be a potential drug against Lym-
phoma.
For that we used CHARMM to look at the stability of disordered regions of Gluco-
corticoid Receptor (from residue 187 to 202) and c-Myc (from residue 42 to 63).
In c-Myc we further studied their interactions with a ligand which is a model drug
compound, representative of a new therapeutic intervention.
19
20
3 Methods
3.1 Intrinsically Disordered predictions
To look at the level of disorder of the Glucocorticoid Receptor, we used different pre-
dictors. These predictors analyse the amino acid composition, the physicochemical
properties of the sequence and the possibility of secondary structure formation. Pre-
dictors derive from machine learning and statistical approaches. We used different
Intrinsically Disordered predictors, such as PONDR, IUPred and SPRITZ. Calculations
done by Professor Anthony Wright.
3.1.1 PONDR
PONDR predicts upon single sequences, using neural networks that use sequence
attributes taken over windows of 9 to 21 amino acids. These attributes, such as
the fractional composition of particular amino acids, hydropathy, or sequence com-
plexity, are averaged over these windows and the values are used to train the neural
network during predictor construction [44]. Those predictors are all well described
in literature [45].
PONDR_fit, PONDR_vL3, PONDR_vls2, PONDR_vltx are different predictors used
in this work, which differentiate from each other on the algorithms used and differ-
ences conditions like coordination number, peptide size [44].
3.1.2 IUPred
IUPred is also a web-server estimating the capacity of polypeptides to form stabil-
ising contacts. The underlying assumption is that globular proteins make a large
number of inter-residue interactions, providing the stabilising energy to overcome
the entropy loss during folding. Taking a set of globular proteins with known struc-
ture, it has developed a simple formalism that allows the estimation of the pairwise
interaction energies of these proteins. It uses a quadratic expression in the amino
acid composition, which takes into account that the contribution of an amino acid
to order/disorder depends not only its own chemical type, but also on its sequential
environment, including its potential interaction partners [46].
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IUPred_long
IUPred_long (long disorder) used in this work encompasses at least 30 consecutive
residues of predicted disorder. For this application the sequential neighbourhood of
100 residues is considered [47].
IUPred_short
UPred_short (short disorder) is suited for predicting short, probably context-dependent,
disordered regions, such as missing residues in the x-ray structure of an otherwise
globular protein. For this application the sequential neighbourhood of 25 residues
is considered. As chain termini of globular proteins are often disordered in x-ray
structures, this is taken into account by an end-adjustment parameter which favours
disorder prediction at the ends [47].
3.1.3 ESPRITZ
ESPRITZ is a web server using two specialised binary classifiers both implemented
with probabilistic soft-margin support vector machines. The long disorder classifier
is trained on a subset of non redundant sequences known to contain only long disor-
dered protein fragments (more than 30 amino acids). The short disorder classifier is
trained instead on a subset of non redundant sequences with only short disordered
fragments [48].
Predictors used in this work use data from NMR (Espritz_nmr) and from x-ray
spectroscopy (Esprits_xray) data.
3.2 Activity measurements
Relative activities were previously obtained by phenotypic screening (data in table
4.1, supplied by Professor Anthony Wright). The biological activity of the Glucocorti-
coid Receptor wild type and their 1 core mutants were measured by -galactosidase
activity expressed the yeast Saccharomyces cerevisiae [23]. Relative activity
Arel corresponds to fraction of the mutant activity Amut and the wild type activity
AWT . See (3.1).
Arel =
Amut
AWT
 100 (3.1)
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3.3 Molecular Dynamics Simulations
The Molecular Dynamics simulations were performed with the program CHARMM
using the force field CHARMM36, except for the compound, using the CGenFF. The
model used is an atomistic representation and the original structures were built
placing the residues in -helix conformation. We simulated the regions from the
residue 187 to 202 (1 core) of Glucocorticoid Receptor and from residue 42 to
63 (MBI) of c-Myc. The simulations were in a cubic box with periodic boundary
conditions of 64Å side for Glucocorticoid Receptor and 72Å side for c-Myc. The box
side corresponds roughly to the protein size with an increase of 40Å. This increment
is also due to Intrinsically Disordered proteins having a more extended structure.
The system was then minimised with 1000 steps of steepest descent algorithm. We
also used harmonic restraints in the peptide backbone, SHAKE algorithm on bonds
containing hydrogens and 11Å cutoff. Afterwards, it was heated from 110K to 330K,
360K and to 400K. The dynamics integrator used is the standard integrator LEAP,
which is based in Verlet leap-frog algorithm, with a 0.002ps timestep.The simulations
were run in constant pressure and temperature (isothermal-isobaric system). For
each system, 10 replicas were simulated for a maximum of 100ns for the 1 core of
Glucocorticoid Receptor and 50ns for MBI of c-Myc protein and these were carried
out in a Graphics Processing Unit of Karoliska Institutet cluster.
The occupancy (range between 0 and 1) is the average number of hydrogen
bonds or hydrophobic contacts formed during the trajectory. This measurement
was used in the simulations of MBI region of c-Myc protein and the ligand to infer
about their interaction.
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4 Results and discussion
4.1 Glucocorticoid Receptor
4.1.1 Mutant selection of 1 core
Previous work done by Professor Anthony Wright is briefly reported here.
Different predictors (described in the previous chapter in 3.1) were used to ac-
cess the levels of structural disorder. In figure 4.1, it is shown the extend of disorder
with the 1 region of the Glucocorticoid Receptor. This region is known to be un-
structured in aqueous solutions and to have three regions with helical propensity
structures by NMR [23]. The helical propensity region H1 is the described 1 core,
which contains nearly 60% to 70% of the biological activity of the entire domain [23].
All these facts are the major reason of choice to perform further studies of the first
helical structure (1 core) of Glucocorticoid Receptor.
Experimental data of the relative biological activity of mutations within the 1
core region (experimental data from literature [23]) and the disordering level are
shown in figure 4.2. It clearly shows an inverse correlation between disorder and
the relative activity of mutants. The relative activity Arel is calculated relatively to
wild type, described in the previous chapter in 3.2.
In this work, fourteen mutated peptide fragments of the 1 core region (residues
187 to 202) were selected from the data of figure 4.2 by presenting a smaller de-
viation from the inverse correlation between relative activity and disorder difference
of the 1 core of Glucocorticoid Receptor.
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Figure 4.1: On the top, schematic representation of Glucocorticoid
Receptor and its three helical propensity regions (H1, H2 and H3)
by different predictors. On the bottom, extent of protein disordered
of the mentioned regions by different predictors. The predictors
are described in the previous chapter in 3.1. Data kindly supplied
by Professor Anthony Wright.
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Figure 4.2: Relation between relative experimental activity Arel
and disorder difference as a function of the relative activity using
IUPred_long
4.1.2 Stability in 1 core
We studied the unfolding of the peptide fragments of the wild type and mutants
of the 1 core of the Glucocorticoid Receptor. We used CHARMM program with
CHARMM36 force field, described in the previous chapter in 3.3.
In figure 4.3, it is the represented a typical dependence between the mean
helicity of the -helix of ten runs and time, for two temperatures. We set up the
runs up to 100ns. The helicity was measured by Kabsch and Sander’s definition of
-helix. If the helicity is near 1, the peptide is close to being in -helix conformation.
On the opposite, if the helicity is close to 0, the peptide is mostly unfolded. Since
we simulated the unfolding of the peptide, it was expected a decrease of helicity
with the increase of time. Comparing the different temperatures, the data from the
simulations at 400K point to a faster unfolding, which it is expected.
We consider a peptide to be more stable, if it shows a slower decrease of he-
licity and vice-versa. Here, it will be introduced a new concept which is helicity first
passage time th. This parameter represents the time (in ns) the helicity takes to
decreases to 0.5, in a number of computational experiments (run). Figure 4.4 is a
typical histogram with the frequency of th for two temperatures. In agreement with
the helicity plot (in figure 4.3), data from the simulations at 400K have in general
an lower th values (in figure 4.3) comparing to the simulations at 360K.
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Figure 4.3: Helicity of 1 core of Glucocorticoid Receptor (wild type)
during 100ns. Each point is an average of 5ns, in order to smooth
the curve, and an average of 10runs. The data represented is
simulations at 360K (blue) and 400K (red).
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Figure 4.4: Frequency of the helicity first passage time th of 1
core of Glucocorticoid Receptor (wild type) during 100ns. The data
represented are the simulations at 360K (blue) and 400K (red).
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Table 4.1: The wild type and mutants and their respective activity,
mean of helicity first passage time and the number of runs used to
calculate the first passage time.
Mutants Arel hthi (ns) at 360K hthi (ns) at 400K N at 360K N at 400K
WT 100 43.58 ± 3.64 24.01 ± 1.60 7 10
L197P 34 18.01 ± 1.74 9.01 ± 0.99 10 10
F199E 34 54.30 ± 4.66 27.01 ± 1.60 7 10
F191E 29 50.01 ± 3.40 35.51 ± 2.03 7 10
L194P 28 37.51 ± 4.46 17.01 ± 1.57 6 10
L197E 30 51.68 ± 4.73 35.72 ± 4.66 6 7
F191D 28 46.26 ± 7.63 12.01 ± 0.67 4 10
I193D 27 45.84 ± 4.13 27.01 ± 3.01 6 10
F191A 44 43.76 ± 3.69 19.01 ± 1.66 8 10
D196Y 281 58.76 ± 5.63 45.01 ± 3.26 4 8
L197V 42 52.51 ± 5.60 25.01 ± 2.12 6 10
L194V 23 42.01 ± 5.08 29.01 ± 2.01 5 10
T190Y 150 21.68 ± 4.19 40.57 ± 2.60 3 9
T190F 150 52.15 ± 2.85 33.90 ± 2.20 7 9
I193F 151 62.51 ± 1.49 31.26 ± 2.52 8 8
Since each run takes its own time to reach half of the helicity, we calculated
an average of helicity first passage time hthi by taking into account a maximum of
10 runs. We calculated hthi and the error associated hthi according to (4.1) and
(4.2), respectively. The number of runs taken into account is N . The table 4.1
shows the mutants, their activity, hthi for both temperature and number of runs
used to calculate them.
hthi =
PN
i=1 thi
N
(4.1)
hthi =
rPN
i=1
(thi th)2
N 1p
N
(4.2)
From table 4.1, we plotted hthi as a function of the activity Arel in figure 4.5.
In figure 4.5a, the graph shows the data simulated at 360k. This appears to be
relatively spread owing to two mutants with a distinguishably lower hthi: the mutant
L197P and the mutant T190Y.
For a deeper understanding, we additionally plotted colourmaps in order to infer
about the structure depending on the residues. In the colourmaps is represented
the number of helical hydrogen bonds present in the 10 runs, by each residue in
each time instant. If it is blue, the bond is present in most of the runs; in case of
white, the bond is mostly absent. In the majority, the main helical region is situated
in the centre of the peptide sequence and they behave similarly to the wild type. See
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figure 4.6a.
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Figure 4.5: The hthi as a function of the activityArel. The simula-
tions for hthi ran for 100ns. Each data point results of the average
up to 10 runs.
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(b) L197P
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(c) L194P
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(d) T190F
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(e) T190Y
Figure 4.6: Sum of helical hydrogen bonds of each amino acid in
every instant at 360K. The sum of helical hydrogen bonds corre-
sponds to all helical hydrogen bonds of 10runs.
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The main helical region of the mutant L197P (in figure 4.6b) looks divided in two
and seems to be very unstable. Prolines do not have the backbone N-H group and
this is because of the conformational restriction imposed by its side chain, which
is a closed ring. The N-H group is involved in the hydrogen bonds and stabilises
an -helix. So this absence affects the conformation, which is clear in figures 4.6b.
Through the colourmap of the mutant L197P becomes evident why its measurement
of hthi is so low.
Curiously, by contrast with L197P (in figure 4.6b), the main helical region of the
mutant L194P (in figure 4.6c) is more stable and shorter than the WT. Even though
the main helical region of L194P is more stable, the remainder amino acids appear
to be mostly unstructured. So, since the hthi accounts for the all region, L194P
(in figure 4.6c) has a smaller hthi compared to WT (in figure 4.6a). With these two
mutants, L197P and L194P, we can ratify the stabilisation effect of Prolines is not
always the same.
Other interesting results are the mutations in T190 (in figures 4.6d and 4.6e).
The mutants T190Y and T190F have high activity. According to our results, both
also have a stable conformation and look to unfold from the c-end into the middle.
This unfolding process is easily seen in figure 4.6d.
Concerning the mutant T190Y, the value obtained for hthi is definitely question-
able. In the figure 4.6e, we can confirm the mutant T190Y has rather high stability.
The reason for such a low measured hthi is it only takes three runs into account. We
were just able to measure three times the th, presumably because the simulation
time was not enough.
Since simulations at 400K point to a faster unfolding, generally we managed
to measure the th in a higher number of runs per mutant. Consequently, hthi at
400K, in figure 4.5b, seem to be more accurate than the ones at 360k.
Every single mutation seems to have an individual effect of helicity/stability
of the 1 core peptide fragment, the changes induced by mutations seem to be
not only quantitive but also qualitative. That being so, it can be speculated that
hthi cannot describe the effect of modification completely or inform about the he-
licity/order/stability of the 1 core region. It seems that a lot is unknown about
structural-function relationship in Intrinsically Disordered regions like in 1 core of
the Glucocorticoid Receptor.
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4.2 c-Myc
4.2.1 MBI alone
Before simulating MBI region of the c-Myc with a compound, we started by simulating
MBI region alone. We adapted the protocol used with 1 core of Glucocorticoid
Receptor to MBI of c-Myc, which is mentioned in the previous chapter in 3.3. We
plotted the colourmaps used with 1 core of Glucocorticoid Receptor, but MBI region
of c-Myc shows different results. The presence of a transient secondary structure
within MBI was mentioned earlier in 1.2.2. In the colourmaps is represented the
number of helical hydrogen bonds present in the 10 runs, by each residue in each
time instant. If it is red, the bond is present in most of the runs; in case of white, the
bond is mostly absent. From figure 4.7a, it is possible to perceive the two regions
described as having helical properties and fluctuating extended character.
The Prolines contribution to the conformational stability of the helical transient
secondary in Intrinsically Disordered proteins has been investigated. The replace-
ment of a N-terminal flanking Proline is related to a decrease of -helical content,
while the replacement of a C-terminal flanking Proline is related to an increase -
helical content [49]. We simulated MBI fragment with a triple-mutation PNA (in figure
4.7b), in which Prolines in N-terminal flanking region were substituted with Alanines
(P42A, P43A and P45A), and a quadruple-mutation PCA (in figure 4.7c), in which
Prolines in C-terminal flanking region were substituted with Alanines (P57A, P59A,
P60A and P63A). The obtained results were in agreement with the mention study
on the Prolines [49], see figure 4.7b and 4.7c. In order to study more deeply the
influence of Prolines in the structure, we simulated the mutants P57A, P59A and
P60A and double mutations, P57A and P59A, P57A and P60A and P59A and P60A
(in figure 4.7). Despite what it is described in the literature, we did not find a more
detailed trend of the role of Prolines on the stabilisation of disordered regions of
c-Myc.
4.2.2 MBI with the compound
The compound structure used here was suggested by Professor Roger Strömberg.
We run simulation with MBI region of c-Myc peptide fragment close by the ligand.
The ligand was design in order to favour the formation of the c-Myc-ligand complex.
We monitored the contacts between the protein and the compound, to see if the
ligand does indeed bind to the peptide as it was designed to do. The binding has
two kinds of interactions: hydrogen bonds and hydrophobic contacts. Hence, we
plotted the binding via these two interactions, in figure 4.9.
32
4.2. c-Myc
Res
idu
e
Time (ns)
42 P43 P
44 A45 P
46 S47 E
48 D49 I
50 W51 K
52 K53 F
54 E55 L
56 L57 P
58 T59 P
60 P61 L
62 S63 P
0 10 20 30 40 50
0
2
4
6
8
10
(a) Wild type
Res
idu
e
Time (ns)
> 42 A> 43 A
44 A> 45 A
46 S47 E
48 D49 I
50 W51 K
52 K53 F
54 E55 L
56 L57 P
58 T59 P
60 P61 L
62 S63 P
0 10 20 30 40 50
0
2
4
6
8
10
(b) PNA (P42A, P43A and P45A)
Res
idu
e
Time (ns)
42 P43 P
44 A45 P
46 S47 E
48 D49 I
50 W51 K
52 K53 F
54 E55 L
56 L> 57 A
58 T> 59 A
> 60 A61 L
62 S> 63 A
0 10 20 30 40 50
0
2
4
6
8
10
(c) PCA (P57A, P59A, P60A and P63A)
Res
idu
e
Time (ns)
42 P43 P
44 A45 P
46 S47 E
48 D49 I
50 W51 K
52 K53 F
54 E55 L
56 L> 57 A
58 T59 P
60 P61 L
62 S63 P
0 10 20 30 40 50
0
2
4
6
8
10
(d) P57A
Res
idu
e
Time (ns)
42 P43 P
44 A45 P
46 S47 E
48 D49 I
50 W51 K
52 K53 F
54 E55 L
56 L57 P
58 T> 59 A
60 P61 L
62 S63 P
0 10 20 30 40 50
0
2
4
6
8
10
(e) P59A
Res
idu
e
Time (ns)
42 P43 P
44 A45 P
46 S47 E
48 D49 I
50 W51 K
52 K53 F
54 E55 L
56 L57 P
58 T59 P
> 60 A61 L
62 S63 P
0 10 20 30 40 50
0
2
4
6
8
10
(f) P60A
Res
idu
e
Time (ns)
42 P43 P
44 A45 P
46 S47 E
48 D49 I
50 W51 K
52 K53 F
54 E55 L
56 L> 57 A
58 T> 59 A
60 P61 L
62 S63 P
0 10 20 30 40 50
0
2
4
6
8
10
(g) P57A and P59A
Res
idu
e
Time (ns)
42 P43 P
44 A45 P
46 S47 E
48 D49 I
50 W51 K
52 K53 F
54 E55 L
56 L> 57 A
58 T59 P
> 60 A61 L
62 S63 P
0 10 20 30 40 50
0
2
4
6
8
10
(h) P57A and P60A
Res
idu
e
Time (ns)
42 P43 P
44 A45 P
46 S47 E
48 D49 I
50 W51 K
52 K53 F
54 E55 L
56 L57 P
58 T> 59 A
> 60 A61 L
62 S63 P
0 10 20 30 40 50
0
2
4
6
8
10
(i) P59A and P60A
Figure 4.7: Sum of helical hydrogen bonds of each amino acid in
every instant at 400K. The sum of helical hydrogen bonds corre-
sponds to all helical hydrogen bonds of 10runs. 33
Chapter 4. Results and discussion
In graphs of figure 4.9, our data point to a stronger hydrophobic interaction
consistent in all three temperatures. This temperature consistency is valid either for
hydrogen bonds and for the hydrophobic contacts. Therefore, the analysis below is
done for 330K, since the scale is expanded.
Looking from the ligand perspective, the range of occupancy levels is higher for
hydrophobic contacts compared to hydrogen bonds. At 330K, the major hydropho-
bic contact occupancy is around 0.8 (in figure 4.9d), while it is around 0.3 for the
highest hydrogen bond occupancy of the ligand (in figure 4.9c). Interestingly, the hy-
drophobic contact points are situated at backbone of compound while the hydrogen
bonding are situated mostly at the extremities of the molecule. See figure 4.9e.
Looking at the contacts of MBI region of c-Myc (in figure 4.9a and 4.9b), we can
verify again that the range of occupancy levels is higher for hydrophobic contacts.
Out data suggest the ligand has the tendency to bind to the residues located at the
middle of the MBI region, more specifically to the Isoleucine (I49), Tryptophan (W50)
and Phenylalanine (F53), with an occupancy levels higher than 0.8. The hydrogen
bonding is mostly done by Lysine (K52), Glutamic Acids (E54 and E47).
A possible top view of the interactions between the ligand and MBI peptide frag-
ment is shown at figure 4.8. The results of this work point to understand if ligand can
be a possible drug to regulate the funtion of c-Myc. Concerning the c-Myc results,
they are still preliminary ones.
Figure 4.8: Schematic figure representing the top view the starting
point of interaction between the c-Myc and ligand. The compound
is supposedly linked in the middle of the helix as suggested by
occupancy results
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(d) Occupancy level for the hydrophobic
contacts interaction of the ligand with MBI
region of c-Myc
(e) Chemical structure of compound with red arrows representing hydrogen bonding and the
hydrophobic points marked with a blue rectangle.
Figure 4.9: Representation of the interactions between MBI region
of c-Myc and the ligand
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5 Conclusion
This work intents to enlighten as to the conformation state of disordered regions of
Glucocorticoid Receptor and c-Myc proteins.
The data on the 1 core of the Glucocorticoid Receptor showed an inverse corre-
lation between relative activity and disorder. We found many single effects in the 1
core but not a general trend between the experimental biological relative activity and
its stability. The data of disordered region MBI of c-Myc analysis showed Prolines
have both a destabilising and stabilising effect. Here again we did not find a deeper
trend on what is responsible for protein order/disorder of this c-Myc fragment. Re-
search in Intrinsically Disordered proteins is a very complex task and lot of it is still
unknown.
Analysis of the interactions between the c-Myc and the ligand showed that hy-
drophobic contacts are the most important kind of interaction, representing an oc-
cupancy levels higher than 0.7 at 330 K. Our data point to the fact that the ligand
is bound to the residues located at the middle of the MBI fragment peptide more
specifically to the Isoleucine (I49), Tryptophan (W50) and Phenylalanine (F53).
The results of this work set new directions to understand the potential of this
ligand as a possible drug to regulate the funtion of c-Myc.
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